Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Proteonomix Establishes New Subsidiary
The goal of PRTMI is to undertake preclinical and clinical trials in regenerative medicine for delivery of therapies, overcoming delays caused by non-clinical considerations. PRTMI intends to interface
The goal of PRTMI is to undertake preclinical and clinical trials in regenerative medicine for delivery of therapies, overcoming delays caused by non-clinical considerations. PRTMI intends to interface
Idera’s proprietary TLR antagonists have dual activity for both TLR7 and TLR9, and is said to present a potentially new approach for the treatment of certain autoimmune diseases.
Reportedly, through this alliance, BASF is expected to add spray drying of APIs and formulations to its offerings as a provider of custom synthesis services for small molecules
The company’s laser particle detection system allows accurate real-time counting, sizing, and data logging of shed particles from each drug-eluting stent during testing, giving a time course of
RTS is expected to pay a minimum of $500,000. Hatch will join its Life Science division, which has successfully served the North American big pharma, biotech and academic
The new entity is created to help grow its bioplastics business. The restructuring provides the division with its own identity and structure under the Biome brand. Biome produces
Rapiacta, an intravenous injection for treatment of influenza infection, was launched for adult use in Japan on January 27, 2010. Shionogi filed a NDA for adult use of
The company said that the certification represents a step toward achieving one of the company’s major goals for its labelstock and RFID facilities worldwide: developing Environmental Management Systems
iGCP trials conform to a set of internationally recognised ethical and scientific quality requirements, providing assurance that data is credible and accurate. Ensuring e-Therapeutics’ clinical trials comply with
The company said that as part of this effort, FDA is committed to being proactive to assist companies with finding opportunities to legally market products that are currently